Myron Kaplan's Common Stock Purchase in CorMedix Inc.

On October 23, 2025, Myron Kaplan, a director of CorMedix Inc., purchased 25,000 shares of the company's common stock at a weighted average price of $11.02 per share. This transaction increased his direct ownership to 201,034 shares. Additionally, Kaplan indirectly owns 20,000 shares through his spouse and 10,000 shares as a guardian for his grandchildren, though he disclaims beneficial ownership of these shares. The purchase was made in multiple transactions at prices ranging from $11.01 to $11.03 per share. Kaplan has agreed to provide full details of the number of shares purchased at each price upon request.